National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 46633 [E8-18270]

Download as PDF Federal Register / Vol. 73, No. 155 / Monday, August 11, 2008 / Notices Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Katrina L. Foster, PhD, Scientific Review Administrator, National Institute on Alcohol Abuse & Alcoholism, National Institutes of Health, 5635 Fishers Lane, Rm. 3042 Rockville, MD 20852, 301– 443–4032, katrina@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants, National Institutes of Health, HHS) and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants, National Institutes of Health, HHS) Dated: July 31 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–18254 Filed 8–8–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: July 31, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–18253 Filed 8–8–08; 8:45 am] National Institutes of Health BILLING CODE 4140–01–M Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meeting rmajette on PRODPC74 with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group; Neuroscience Review Subcommittee. Date: November 13–14, 2008. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Beata Buzas, PhD, Scientific Review Administrator, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Lane, Rm 3041, Rockville, MD 20852, 301– 443–0800, bbuzas@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists VerDate Aug<31>2005 15:22 Aug 08, 2008 Jkt 214001 Name of Committee: National Institute of Allergy and Infectious Diseases, Special Emphasis Panel NIAID Clinical Trial Planning (R34) Grants (DMID). Date: September 2, 2008. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Barney Duane Price, PhD, Scientific Review Officer, Scientific Review Program, DHHS/NIH/NIAID/DEA, Room 3139, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 451–2592, pricebd@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases, Special Emphasis Panel NIAID Clinical Trial Planning (R34) Grants (DAIDS). Date: September 2, 2008. Time: 12 p.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Barney Duane Price, PhD, Scientific Review Officer, Scientific Review Program, DHHS/NIH/NIAID/DEA, Room 3139, 6700B Rockledge Drive, MSC 7616, PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 46633 Bethesda, MD 20892–7616, 301–451–2592, pricebd@niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases, Special Emphasis Panel Infectious Diseases, Transmission in the Developing World. Date: September 3, 2008. Time: 10:30 a.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700 B Rockledge Drive, 3259, Bethesda, MD 20817 (Telephone Conference Call). Contact Person: Edward W. Schroder, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, NIAID, NIH, Room 2156, 6700–B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, (301) 496–2550. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 1, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–18270 Filed 8–8–08; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences, Special Emphasis Panel, R13 Scientific Conference Grants. Date: August 20, 2008. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute of General Medical Sciences, Office of Scientific Review, Building 45, Room 3AN18, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Margaret Weidman, PhD, Scientific Review Officer, Office of Scientific E:\FR\FM\11AUN1.SGM 11AUN1

Agencies

[Federal Register Volume 73, Number 155 (Monday, August 11, 2008)]
[Notices]
[Page 46633]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18270]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel NIAID Clinical Trial Planning (R34) 
Grants (DMID).
    Date: September 2, 2008.
    Time: 1 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Barney Duane Price, PhD, Scientific Review 
Officer, Scientific Review Program, DHHS/NIH/NIAID/DEA, Room 3139, 
6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, (301) 451-2592, 
pricebd@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel NIAID Clinical Trial Planning (R34) 
Grants (DAIDS).
    Date: September 2, 2008.
    Time: 12 p.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Barney Duane Price, PhD, Scientific Review 
Officer, Scientific Review Program, DHHS/NIH/NIAID/DEA, Room 3139, 
6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-451-
2592, pricebd@niaid.nih.gov.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel Infectious Diseases, Transmission 
in the Developing World.
    Date: September 3, 2008.
    Time: 10:30 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700 B Rockledge Drive, 
3259, Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Edward W. Schroder, PhD, Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, NIAID, NIH, Room 2156, 6700-B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892-7616, (301) 496-2550.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 1, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-18270 Filed 8-8-08; 8:45 am]
BILLING CODE 4140-01-M